News & Updates

Show Multimedia Only

Tirzepatide proves safety, efficacy in T1D in real world

09 Oct 2025 by

The use of tirzepatide in a real-world setting demonstrates a favourable safety profile and results in weight loss, lower insulin requirements, and better glycaemic measurements among patients with type 1 diabetes (T1D), as shown in a study presented at EASD 2025.

09 Oct 2025

Oral disorders prevalent in patients with diabetes

09 Oct 2025 by

A study reports a strong correlation between diabetes and oral pathologies, particularly malignancies and periodontal disease.

09 Oct 2025

Old drug, new purpose: Low-dose ATG may halt T1D progression in youths

08 Oct 2025 by

The old immunomodulatory drug antithymocyte globulin (ATG), administered at a low dose, can safely reduce the loss of beta-cell function in young people with recent-onset type 1 diabetes (T1D), as shown in the phase II MELD-ATG trial.

08 Oct 2025

Engaging in physical activity may prevent MACE, death in people with T2D

08 Oct 2025 by

An inverse association exists between self-reported physical activity (PA) and the risk of major adverse cardiac events (MACE) and all-cause mortality among individuals with type 2 diabetes (T2D) and no previous cardiovascular disease (CVD), suggests a study presented at EASD 2025.

08 Oct 2025

Oxidative balance score inversely linked to advanced CKM risk

07 Oct 2025

Higher levels of oxidative balance score (OBS) are associated with a lower risk of advanced cardiovascular‒kidney‒metabolic (CKM) syndrome, reveals a study.

07 Oct 2025

Novel cannabinoid receptor 1 inverse agonist a promising medication for obesity

07 Oct 2025

Treatment with the novel cannabinoid receptor 1 (CB1R) inverse agonist monlunabant appears to yield significant and clinically meaningful weight loss in adults with obesity and metabolic syndrome, according to a phase IIa trial.

07 Oct 2025

Does eating unprocessed red meat lead to obesity?

06 Oct 2025 by

Consumption of unprocessed red meat (URM) shows no significant effect on weight gain, obesity, or related metabolic conditions, according to the results of a systematic review and meta-analysis.

06 Oct 2025

Overweight, obesity protective against death?

06 Oct 2025 by

A large study from Denmark presented at EASD 2025 suggests that overweight and obesity may protect against death.

06 Oct 2025

Physician-led reviews may prevent overprescription in psychiatric patients

04 Oct 2025 by

Implementation of physician-led medication reviews through interdisciplinary dialogue can reduce the number of prescribed drugs and potentially inappropriate prescriptions (PIPs) in psychiatric outpatients with coexisting diabetes, a study has shown.

04 Oct 2025

Sarcopenia plus obesity a greater risk factor for frailty, functional decline

03 Oct 2025 by

The presence of both sarcopenia and obesity compounds the risks of frailty, functional decline, cognitive impairment, and mobility limitations compared with either condition alone, according to a study from Singapore.

03 Oct 2025

News & Updates

Showing Endocrinology articles

Showing

Specialty:

Tirzepatide proves safety, efficacy in T1D in real world

Oral disorders prevalent in patients with diabetes

Old drug, new purpose: Low-dose ATG may halt T1D progression in youths

Engaging in physical activity may prevent MACE, death in people with T2D

Oxidative balance score inversely linked to advanced CKM risk

Novel cannabinoid receptor 1 inverse agonist a promising medication for obesity

Does eating unprocessed red meat lead to obesity?

Overweight, obesity protective against death?

Physician-led reviews may prevent overprescription in psychiatric patients

Sarcopenia plus obesity a greater risk factor for frailty, functional decline